4//SEC Filing
Mortensen Eric R. 4
Accession 0001144204-19-012634
CIK 0001175151other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 9:09 PM ET
Size
6.0 KB
Accession
0001144204-19-012634
Insider Transaction Report
Form 4
Mortensen Eric R.
Chief Medical Officer
Transactions
- Award
Common Stock
2019-03-04+4,620→ 34,166 total
Footnotes (2)
- [F1]These shares represent restricted stock units ("RSUs") which shall vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and will be settled into common stock upon vesting.
- [F2]Includes (i) the 20,000 RSUs granted on March 15, 2018 that will be settled into common stock upon a "Change In Control" of CytoSorbents Corporation, as defined in the 2014 Long-Term Incentive Plan, (ii) the following RSUs subject to vesting as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date, and that will be settled into common stock upon vesting: (a) 4,667 RSUs granted on February 28, 2018 and (b) 4,620 RSUs granted on March 4, 2019 and reported on this Form 4, and (iii) 4,879 shares of common stock owned by the reporting person.
Documents
Issuer
Cytosorbents Corp
CIK 0001175151
Entity typeother
Related Parties
1- filerCIK 0001708454
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 9:09 PM ET
- Size
- 6.0 KB